Intracranial Myxoid Mesenchymal Tumour with EWSR1-ATF1 Fusion Sans Myxoid Stroma - Report of A Newer Entity with Brief Review of Literature.

Intracranial myxoid mesenchymal tumors (IMMTs) are a relatively new group of tumors, first described in 2017. We report this rare variant in a 27-year-old female which was initially suspected to be a high-grade glial neoplasm. Next-generation sequencing confirmed the presence of fusion between the FET and cAMP response element-binding (CREB) family of genes. This fusion is diagnostic of IMMT, with only 19 such cases reported so far. The authors would like to highlight the need for genomic sequencing for the diagnosis of this tumor, its propensity to recur locally, and its relatively better prognosis as compared to high-grade gliomas.

[1]  G. Reifenberger,et al.  The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. , 2021, Neuro-oncology.

[2]  D. Tran,et al.  Intracranial myxoid mesenchymal neoplasms with EWSR1 gene rearrangement: report of 2 midline cases with one demonstrating durable response to MET inhibitor monotherapy , 2021, Neuro-oncology advances.

[3]  J. Liu,et al.  Adult intracranial myxoid mesenchymal tumor with EWSR1-ATF1 gene fusion. , 2020, World neurosurgery.

[4]  Jorge Lima,et al.  Myxoid mesenchymal intraventricular brain tumour with EWSR1–CREB1 gene fusion in an adult woman , 2020, Virchows Archiv.

[5]  G. Fuller,et al.  Intracranial Myxoid Mesenchymal Tumor With EWSR1-ATF1 Fusion. , 2020, Journal of neuropathology and experimental neurology.

[6]  Thomas M Pearce,et al.  Intracranial Myxoid Mesenchymal Tumor with Rare EWSR1-CREM Translocation , 2019, Pediatric Neurosurgery.

[7]  R. Sciot,et al.  Primary myxoid mesenchymal tumour with intracranial location: report of a case with a EWSR1–ATF1 fusion , 2018, Histopathology.

[8]  K. Ligon,et al.  Intracranial myxoid mesenchymal tumors with EWSR1–CREB family gene fusions: myxoid variant of angiomatoid fibrous histiocytoma or novel entity? , 2018, Brain pathology.

[9]  C. Antonescu,et al.  EWSR1 Fusions With CREB Family Transcription Factors Define a Novel Myxoid Mesenchymal Tumor With Predilection for Intracranial Location , 2017, The American journal of surgical pathology.

[10]  T. Strojnik,et al.  Prognostic value of erythrocyte sedimentation rate and C-reactive protein in the blood of patients with glioma. , 2014, Anticancer research.